Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsored by: |
National Heart, Lung, and Blood Institute (NHLBI) |
---|---|
Information provided by: | National Heart, Lung, and Blood Institute (NHLBI) |
ClinicalTrials.gov Identifier: | NCT00000603 |
To evaluate if HLA-mismatched, unrelated-donor umbilical cord blood stem and progenitor cell units (UCBU) offered a clinically acceptable alternative to matched unrelated-donor allogeneic bone marrow for transplantation with 180-day disease free survival as the endpoint. HLA typing was performed using DNA-base high resolution methods to determine HLA alleles. Patients with "true" HLA 3/6 and 4/6 matches were evaluated. In addition, a separate study in adults addressed the problem of limited cell dose and engraftment failure. The study was not planned as a randomized comparative clinical trial. Instead, it is a phase II/III efficacy study.
Condition | Intervention | Phase |
---|---|---|
Anemia, Aplastic Fanconi Anemia Hematologic Diseases Leukemia Neoplasms Severe Combined Immunodeficiency Hematopoietic Stem Cell Transplantation Myelodysplastic Syndromes |
Procedure: stem cell transplantation |
Phase II |
Study Type: | Interventional |
Study Design: | Treatment |
Study Start Date: | September 1996 |
Study Completion Date: | October 2007 |
Primary Completion Date: | October 2007 (Final data collection date for primary outcome measure) |
Ages Eligible for Study: | up to 55 Years |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Mothers of Infant-donors must complete a medical history form, have an uncomplicated delivery, and deliver at UCLA or Duke.
Patients are those who need a transplant but don't have a matched marrow donor or can't wait to find one.
Study ID Numbers: | 316 |
Study First Received: | October 27, 1999 |
Last Updated: | January 18, 2008 |
ClinicalTrials.gov Identifier: | NCT00000603 |
Health Authority: | United States: Federal Government |
Myelodysplastic syndromes Metabolic Diseases Precancerous Conditions Hematologic Diseases Severe Combined Immunodeficiency Fanconi Anemia Myelodysplasia Myelodysplastic Syndromes Anemia Immunologic Deficiency Syndromes |
Leukemia Preleukemia Fanconi's anemia Genetic Diseases, Inborn Anemia, Aplastic Infant, Newborn, Diseases Severe combined immunodeficiency Metabolic disorder Aplastic anemia Bone Marrow Diseases |
Neoplasms Pathologic Processes Disease Neoplasms by Histologic Type |
Anemia, Hypoplastic, Congenital Immune System Diseases Syndrome DNA Repair-Deficiency Disorders |